Evaluation of Clinical Success of Bulk Fil Composite Versus Highly Viscous Glass Ionomer in Primary Class II Molars

NCT ID: NCT06235489

Last Updated: 2024-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-01

Study Completion Date

2024-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

evaluate the clinical performance of EQUIA Forte ® ( a HVGIC) and Plafique® Bulk Flow composite resin when placed in class II cavities in primary molars.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Thorough diagnosis of patients will be done by the primary investigator. Patients with class II carious primary molars with score 4 or 5 using the International Caries Detections and Assessment Criteria (ICDAS).
2. Pre-operative bitewing radiographs will be obtained to assess the depth of the cavity. Primary molars with score D1 or D2 according to the ADA will be included in the study.
3. Each patient will be assigned to one of the two groups.

* Group I (n= 59): Plafique Bulk Flow Composite.
* Group II (n=59): EQUIA Forte Group.
4. Class II carious primary molars are prepared using 330 burs. The cavity will be approximately with a depth of 0.5 mm in dentin and width of at least one-third of the occlusal table. Outline of the cavity will be determined by the extent of the carious lesion. No beveling will be done in any of the cavities.
5. Matrix is placed and secured in position.
6. One of the 2 restorative materials is placed in the cavity using the manufacturer's instructions.
7. Patients will be recalled at 3, 6, and 12 months to evaluate the restoration clinically using the FDI criteria.
8. Patients will receive oral health education on how to maintain a proper oral hygiene and proper diet consumption.
9. They will be given manual tooth brushes and tooth pastes to use during the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries Class II

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Palfique Bulk Flow bulk-fil flowable restorative material

Procedure: restoration of proximal cavities of primary molars with bulk-fil flowable composite removal of proximal caries of primary molars and restoration of the cavities prepared by Palfique bulk flow

Group Type EXPERIMENTAL

Palfique Bulk Flow

Intervention Type OTHER

removal of caries in primary molars and placement of restorative materials

Glass-hybrid added HVGIC Equia Forte HT Glass-hyrbid-added highly viscous glass ionomer cement

Procedure: Restoration of proximal cavities of primary molars with highly viscous glass ionomer cement removal of proximal caries of primary molars and restoration of the cavities prepared by the Equia forte HT

Group Type ACTIVE_COMPARATOR

Palfique Bulk Flow

Intervention Type OTHER

removal of caries in primary molars and placement of restorative materials

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Palfique Bulk Flow

removal of caries in primary molars and placement of restorative materials

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Equia Forte HT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Four to 8 years old children
* Cooperative children classified as class 3 or 4 based on Frankle et al. classification.
* Presence of deep bite or any type of malocclusion or parafunctional habits.
* Children who have at least one primary molar with active proximal caries (score 4 or 5 using ICDAS).

Exclusion Criteria

* Refusal of the parents to sign the informed consent.
* Presence of deep bite or any type of malocclusion or parafunctional habits.
Minimum Eligible Age

4 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mariam Mohamed Abdel Azim

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mariem O Wassel, Prof

Role: STUDY_DIRECTOR

Head of Pediatric Dentistry Department, Faculty of Dentistry, Ain Shams University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry, Ain Shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mariam M Abdel Azim, Ass. Lec

Role: CONTACT

0122841611 ext. +20

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mariam M Abdel Azim, Ass. Lec

Role: primary

01282841611 ext. +20

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PED 22-5D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.